ConductScience.org, home

Paper320661

Control of influenza and poliomyelitis with killed virus vaccines.

Salk J and 1 other. Science, 1977. Cited by 144 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Control of influenza and poliomyelitis with killed virus vaccines. Papers, record 320661. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/320661

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Control of influenza and poliomyelitis with killed virus vaccines.
PubMed
Journal
Science
PubMed
Year
1977
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
144
iCite
Relative citation ratio, by iCite
3.3
iCite
Revised in PubMed
2022-03-31
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salk JJ
2Salk DD

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Influenza VaccinesMajor topic
Influenza, HumanMajor topic
PoliomyelitisMajor topic
Poliovirus Vaccine, InactivatedMajor topic
Adjuvants, Immunologic
Antibodies, Viral
Antigens, Viral
Europe
Humans
Mineral Oil
Orthomyxoviridae
Time Factors
United States
Vaccination
Vaccines, Attenuated

Source PubMed

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.

PMIDTitleJournalYearIn PapersSource
41,905,532Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus.Virol Sin2026https://conductscience.org/library/papers/41905532PubMed
39,794,927Preferences for and drivers of adult vaccination clinic site selection: A cross-sectional study in 30 provinces in China.Hum Vaccin Immunother2025https://conductscience.org/library/papers/39794927PubMed
38,250,843Nanoparticles and Antiviral Vaccines.Vaccines (Basel)2023https://conductscience.org/library/papers/38250843PubMed
37,008,622Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination.J Clin Transl Sci2023https://conductscience.org/library/papers/37008622PubMed
34,787,781Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology.Bull Exp Biol Med2021https://conductscience.org/library/papers/34787781PubMed
32,287,579Chapter 4 Picornavirus infections.Perspect Med Virol1985https://conductscience.org/library/papers/32287579PubMed
30,637,122The PathLink Acquired Gestational Tissue Bank: Feasibility of Project PLACENTA.J Reprod Biotechnol Fertil2018https://conductscience.org/library/papers/30637122PubMed
28,025,504Reverse Genetics Approaches for the Development of Influenza Vaccines.Int J Mol Sci2016https://conductscience.org/library/papers/28025504PubMed
28,004,787Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum.Sci Rep2016https://conductscience.org/library/papers/28004787PubMed
23,960,760Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.Saudi Pharm J2011https://conductscience.org/library/papers/23960760PubMed
23,824,369Traditional and new influenza vaccines.Clin Microbiol Rev2013https://conductscience.org/library/papers/23824369PubMed
21,206,484Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.Mol Ther2011https://conductscience.org/library/papers/21206484PubMed
19,931,408Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.J Autoimmun2010https://conductscience.org/library/papers/19931408PubMed
19,135,117A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.Vaccine2009https://conductscience.org/library/papers/19135117PubMed
17,917,038Immunity and protection, the unfolding of a tale.Immunol Res2007https://conductscience.org/library/papers/17917038PubMed
16,792,682Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-gamma production and cross-strain reactivity.Clin Exp Immunol2006https://conductscience.org/library/papers/16792682PubMed
15,951,823Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.Nat Med2005https://conductscience.org/library/papers/15951823PubMed
12,059,113The development and use of vaccine adjuvants.Mol Biotechnol2002https://conductscience.org/library/papers/12059113PubMed
11,101,561Improved genotyping vaccine and wild-type poliovirus strains by restriction fragment length polymorphism analysis: clinical diagnostic implications.J Clin Microbiol2000https://conductscience.org/library/papers/11101561PubMed
9,311,873Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice.J Virol1997https://conductscience.org/library/papers/9311873PubMed

See all 38 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/320661

GET https://conductscience.org/api/papers/v1/320661/cited_by?page=2